標(biāo)題: Titlebook: Cancer Imaging with Radiolabeled Antibodies; David M. Goldenberg Book 1990 Kluwer Academic Publishers 1990 Antigen.Staging.Tumor.carcinoma [打印本頁(yè)] 作者: FETUS 時(shí)間: 2025-3-21 17:58
書目名稱Cancer Imaging with Radiolabeled Antibodies影響因子(影響力)
書目名稱Cancer Imaging with Radiolabeled Antibodies影響因子(影響力)學(xué)科排名
書目名稱Cancer Imaging with Radiolabeled Antibodies網(wǎng)絡(luò)公開度
書目名稱Cancer Imaging with Radiolabeled Antibodies網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Cancer Imaging with Radiolabeled Antibodies被引頻次
書目名稱Cancer Imaging with Radiolabeled Antibodies被引頻次學(xué)科排名
書目名稱Cancer Imaging with Radiolabeled Antibodies年度引用
書目名稱Cancer Imaging with Radiolabeled Antibodies年度引用學(xué)科排名
書目名稱Cancer Imaging with Radiolabeled Antibodies讀者反饋
書目名稱Cancer Imaging with Radiolabeled Antibodies讀者反饋學(xué)科排名
作者: 厚臉皮 時(shí)間: 2025-3-21 21:08
0927-3042 cology text- books are generally out of date. Single papers in specialized journals are informative but seldom comprehensive; these are more often preliminary reports on a very limited number of patients. Certain general journals frequently publish good in-depth reviews of cancer topics, and publish作者: amnesia 時(shí)間: 2025-3-22 03:22
https://doi.org/10.1007/978-3-030-00698-3d biologic problems that need to be solved. At present fairly superficial lesions, between 1/2 and 1 cm in diameter, are likely to be detected with an optimal combination of attainable factors. Theoretically, for the majority of tumors, the technique is not significantly more sensitive than several other imaging methods.作者: floodgate 時(shí)間: 2025-3-22 06:05 作者: 混沌 時(shí)間: 2025-3-22 12:06 作者: GNAW 時(shí)間: 2025-3-22 13:51
Physiology of monoclonal antibody accretion by tumorsantibodies have been generated using human tumor cell lines [2,3] and tumor homogenates [3,4] as the source of immunogen. Many of these antibodies when ‘tagged’ with radionuclides have produced radioimmunodiagnostic and radioimmunotherapeutic agents for use in either animal experiments or in the clinic [5–19].作者: GNAW 時(shí)間: 2025-3-22 20:37 作者: 怕失去錢 時(shí)間: 2025-3-22 23:37
Allan Cain,Ivar Kolstad,Arne Wiigation when preparing immunoconjugates with other chemical moieties is the preservation of immunoreactivity, and at the same time, sufficient quantities of the agents must be bound to the antibody so that a therapeutic effect can result. Binding must also persist with a long enough half-life to deliver an adequate dose of the agents to the target.作者: 克制 時(shí)間: 2025-3-23 02:28
Godwin’s Popular Stories for the Nurseryrticularly as radiolabeling methods with a higher photon flux are becoming available and with the use of background subtraction, a method of delivering more antibody to tumors and less to normal tissues would be most valuable [7–10].作者: Fraudulent 時(shí)間: 2025-3-23 06:26
Intraperitoneal delivery of monoclonal antibodiesrticularly as radiolabeling methods with a higher photon flux are becoming available and with the use of background subtraction, a method of delivering more antibody to tumors and less to normal tissues would be most valuable [7–10].作者: RUPT 時(shí)間: 2025-3-23 12:14
Preclinical models and methods for the study of radiolabeled monoclonal antibodies in cancer diagnos forming cells, numerous monoclonal antibodies have been generated against human and animal cancer cell surface markers for their potential use in cancer diagnosis and therapy [2–4]. To better understand the clinical utility of these antibodies, various animal models have been utilized.作者: Negotiate 時(shí)間: 2025-3-23 17:19 作者: EWE 時(shí)間: 2025-3-23 21:20 作者: ciliary-body 時(shí)間: 2025-3-24 00:37
Requirements for the use of radioimmunodetection of cancer in clinical practiceSince its first application in human subjects [1], a wide experience has been acquired by several groups in radioimmunodetection (RAID) of different tumors.作者: Airtight 時(shí)間: 2025-3-24 04:25 作者: Cloudburst 時(shí)間: 2025-3-24 09:36 作者: 不規(guī)則的跳動(dòng) 時(shí)間: 2025-3-24 11:26 作者: 擴(kuò)音器 時(shí)間: 2025-3-24 16:46
Godwin’s Fear of the Private Affections forming cells, numerous monoclonal antibodies have been generated against human and animal cancer cell surface markers for their potential use in cancer diagnosis and therapy [2–4]. To better understand the clinical utility of these antibodies, various animal models have been utilized.作者: Campaign 時(shí)間: 2025-3-24 21:07
Eliza O’Brien,Helen Stark,Beatrice Turner exquisite specificity and great utility for the diagnosis and treatment of cancer and other diseases [1]. Over the past 11 years numerous monoclonal antibodies have been generated using human tumor cell lines [2,3] and tumor homogenates [3,4] as the source of immunogen. Many of these antibodies whe作者: 抗生素 時(shí)間: 2025-3-24 23:21 作者: alleviate 時(shí)間: 2025-3-25 05:41 作者: Sleep-Paralysis 時(shí)間: 2025-3-25 11:04 作者: 救護(hù)車 時(shí)間: 2025-3-25 14:26 作者: hurricane 時(shí)間: 2025-3-25 19:38
Allan Cain,Ivar Kolstad,Arne Wiigor in-vivo diagnostic studies. In many instances monoclonal antibodies have progressed from research bioassays to radiopharmaceuticals for radioimmunodetection of cancers and, theoretically, the same antibodies in the form of immunoconjugates could be applied to cancer therapy. The critical consider作者: needle 時(shí)間: 2025-3-25 23:42
Christopher Alden,Ana Cristina Alves.In, and .I [1–9]. More recently, however, increasing efforts have been expended to label these reagents with .Tc. Indeed, successful clinical application of commercial monoclonal antibody imaging products will probably be dependent on the development of simple, inexpensive methods to label antibody作者: 航海太平洋 時(shí)間: 2025-3-26 00:24
New Approaches to the Treatment of Leukemiae lesions by indirectly demonstrating a decrease in the accretion of the radiopharmaceutical (negative image) or by a physiologic attribute of the tissue that permits a positive image of the lesion. For example, to the extent that a tumor lacks organ-specific properties, an organ-imaging agent could作者: BLANC 時(shí)間: 2025-3-26 05:02
https://doi.org/10.1007/978-3-642-75484-5lonal antibodies (Mab) [1–4]. Previous investigators have evaluated the clinical utility of radiolabeled monoclonal antibodies for diagnosing the metastatic spread of melanoma [5–8], prostatic cancer [9], colorectal cancer [10–13], and several other malignancies, as well as nonmalignant conditions s作者: 即席演說 時(shí)間: 2025-3-26 11:58
https://doi.org/10.1007/978-1-4613-1497-4Antigen; Staging; Tumor; carcinoma; diagnosis; imaging; interferon; physiology; surgery作者: esoteric 時(shí)間: 2025-3-26 16:01 作者: 移動(dòng) 時(shí)間: 2025-3-26 18:27 作者: 植物學(xué) 時(shí)間: 2025-3-26 22:37 作者: irradicable 時(shí)間: 2025-3-27 03:54
Clinical radioimmunodetection: The second decadet-term remissions were obtained in a few patients [12–14]. In 1965, Mahaley and Day reported on the localization of antibodies in gliomas in patients by means of autoradiography on excised specimens [15]. Finally, using radiolabeled antibodies to an undefined renal cancer antigen, Belitsky et al. [1作者: Synapse 時(shí)間: 2025-3-27 07:06 作者: Manifest 時(shí)間: 2025-3-27 13:07
Radiolabeling antibodies via the cyclic anhydride of DTPA — Experiences of 5 years used extensively in this and other laboratories for the preparation of DTPA-conjugated antibodies and other proteins. For example, in addition to both polyclonal and monoclonal antibodies, other proteins have been conjugated, such as fibrinogen [6,7], albumin [5], tissue plasminogen activator [8], 作者: PET-scan 時(shí)間: 2025-3-27 15:38 作者: 退出可食用 時(shí)間: 2025-3-27 18:23 作者: LAIR 時(shí)間: 2025-3-27 21:59 作者: ASSAY 時(shí)間: 2025-3-28 04:25
In-vivo antibody imaging for the detection of human tumorsat radio-iodinated antibodies prepared against extracts of rodent tumors could localize in these tumors selectively [1,4,5]. Subsequently, it was found that this preferential tumor accretion of the radioactive antibodies was due mainly to anti-fibrin antibodies [1,6–8]; anti-fibrinogen antibodies we作者: NOCT 時(shí)間: 2025-3-28 06:44 作者: irritation 時(shí)間: 2025-3-28 11:05 作者: cutlery 時(shí)間: 2025-3-28 18:06
https://doi.org/10.1007/978-3-030-00698-3or-specific antibodies could be generated. Pressman and Korngold [4] demonstrated selective tumor targeting in mice bearing the Wagner-osteogenic mouse sarcoma cell line. One of the earliest antigens used to localize humans tumors was fibrin [5], and I-131-labeled antibodies to fibrin were used in t作者: 暴露他抗議 時(shí)間: 2025-3-28 18:51 作者: 沙文主義 時(shí)間: 2025-3-28 23:00 作者: grenade 時(shí)間: 2025-3-29 06:17 作者: 全能 時(shí)間: 2025-3-29 10:24
Christopher Alden,Ana Cristina Alvesrts have been made to use a ligand to attach .Tc indirectly to the antibody. The second approach has been to bind the radionuclide directly to intrinsic receptor sites or to altered groups of the protein backbone of the antibody molecule.作者: cognizant 時(shí)間: 2025-3-29 14:23 作者: 存在主義 時(shí)間: 2025-3-29 16:28
https://doi.org/10.1007/978-3-642-75484-5ose of other workers, have been reviewed previously [17–19]. In this chapter we will review our experience in colorectal cancer immunoscintigraphy using In-111-labeled intact monoclonal antibody as well as F(ab’). fragments. We will first discuss advantages and/or disadvantages of the radio-labels u作者: 可以任性 時(shí)間: 2025-3-29 22:56 作者: erythema 時(shí)間: 2025-3-30 01:24
0927-3042 fashion: first, by dividing the oncology literature into specific subdivisions such as lung cancer, genitourinary cancer, pediatric oncology, etc.; and second, 978-1-4612-8805-3978-1-4613-1497-4Series ISSN 0927-3042 Series E-ISSN 2509-8497 作者: 含鐵 時(shí)間: 2025-3-30 05:12 作者: insurrection 時(shí)間: 2025-3-30 09:40 作者: panorama 時(shí)間: 2025-3-30 12:49
Antibody targeting: Theoretical considerationsreby developed into mathematical models to assess the potential and limitations of the technique. This allows a clear understanding of the physical and biologic problems that need to be solved. At present fairly superficial lesions, between 1/2 and 1 cm in diameter, are likely to be detected with an作者: 不能根除 時(shí)間: 2025-3-30 20:21
Experimental model systems for antibody targeting and radioimmunodetectionf animal models in radiotracer studies, including radiolabled antibodies, has been reviewed [1]. The first animal studies in the field of radioimmunodetection (RAID) were performed in the late 1940s and early 1950s. In a study to determine if anti-organ antibodies could localize specifically to the 作者: Pigeon 時(shí)間: 2025-3-30 23:05
Preclinical models and methods for the study of radiolabeled monoclonal antibodies in cancer diagnos forming cells, numerous monoclonal antibodies have been generated against human and animal cancer cell surface markers for their potential use in cancer diagnosis and therapy [2–4]. To better understand the clinical utility of these antibodies, various animal models have been utilized.作者: 效果 時(shí)間: 2025-3-31 01:21
Physiology of monoclonal antibody accretion by tumors exquisite specificity and great utility for the diagnosis and treatment of cancer and other diseases [1]. Over the past 11 years numerous monoclonal antibodies have been generated using human tumor cell lines [2,3] and tumor homogenates [3,4] as the source of immunogen. Many of these antibodies whe作者: Dislocation 時(shí)間: 2025-3-31 06:24 作者: 熄滅 時(shí)間: 2025-3-31 12:07 作者: canvass 時(shí)間: 2025-3-31 16:28 作者: 無關(guān)緊要 時(shí)間: 2025-3-31 20:50
